Christopher Budde, Chief Commercial Officer of United States Cell Signaling Technology, Inc (CST company) and Jay Dong, Vice President and General Manager of Asia-Pacific region, visited Shanghai Institute of Immunology(SII) on July 15, 2016. Dr.Li Yu, Dr.Shen Lei and Dr.Huang Chuanxin gave a warm welcome and showed them around the instrument platforms of our Institute on behalf of Prof.Su Bing, Director of Shanghai Institute of Immunology.
US Cell Signaling Technology, Inc (CST) was established in 1999, which is the world's leading biotechnology company, especially renowned in the field of cellular signal transduction. Its high-quality products and professional R & D spirits have been respected as "the Gold Standard for Cell Signaling Research" by the worldwide customers.
Further strategic cooperations between Shanghai Institute of Immunity and US CST company were well discussed and both sides are expected to work together in the future focusing on the PTMScan platform construction, antibody development and other aspects, which will provide the most cutting-edge means and tools for protein modification studies.
